5-132682252-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000589.4(IL4):​c.361-234A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 150,096 control chromosomes in the GnomAD database, including 11,860 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 11860 hom., cov: 31)

Consequence

IL4
NM_000589.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.554

Publications

25 publications found
Variant links:
Genes affected
IL4 (HGNC:6014): (interleukin 4) The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. IL4 is considered an important cytokine for tissue repair, counterbalancing the effects of proinflammatory type 1 cytokines, however, it also promotes allergic airway inflammation. Moreover, IL-4, a type 2 cytokine, mediates and regulates a variety of human host responses such as allergic, anti-parasitic, wound healing, and acute inflammation. This cytokine has been reported to promote resolution of neutrophil-mediated acute lung injury. In an allergic response, IL-4 has an essential role in the production of allergen-specific immunoglobin (Ig) E. This pro-inflammatory cytokine has been observed to be increased in COVID-19 (Coronavirus disease 2019) patients, but is not necessarily associated with severe COVID-19 pathology. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.757 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000589.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
NM_000589.4
MANE Select
c.361-234A>G
intron
N/ANP_000580.1
IL4
NM_172348.3
c.313-234A>G
intron
N/ANP_758858.1
IL4
NM_001354990.2
c.*51-234A>G
intron
N/ANP_001341919.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
ENST00000231449.7
TSL:1 MANE Select
c.361-234A>G
intron
N/AENSP00000231449.2
IL4
ENST00000350025.2
TSL:1
c.313-234A>G
intron
N/AENSP00000325190.3
IL4
ENST00000622422.1
TSL:1
c.*51-234A>G
intron
N/AENSP00000480581.1

Frequencies

GnomAD3 genomes
AF:
0.338
AC:
50712
AN:
149978
Hom.:
11829
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.0170
Gnomad AMR
AF:
0.341
Gnomad ASJ
AF:
0.208
Gnomad EAS
AF:
0.778
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.176
Gnomad NFE
AF:
0.159
Gnomad OTH
AF:
0.296
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.338
AC:
50802
AN:
150096
Hom.:
11860
Cov.:
31
AF XY:
0.346
AC XY:
25321
AN XY:
73234
show subpopulations
African (AFR)
AF:
0.603
AC:
24823
AN:
41160
American (AMR)
AF:
0.341
AC:
5158
AN:
15132
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
716
AN:
3450
East Asian (EAS)
AF:
0.777
AC:
3991
AN:
5134
South Asian (SAS)
AF:
0.204
AC:
934
AN:
4582
European-Finnish (FIN)
AF:
0.373
AC:
3801
AN:
10184
Middle Eastern (MID)
AF:
0.186
AC:
54
AN:
290
European-Non Finnish (NFE)
AF:
0.159
AC:
10689
AN:
67202
Other (OTH)
AF:
0.299
AC:
621
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1380
2761
4141
5522
6902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
1915
Bravo
AF:
0.353
Asia WGS
AF:
0.484
AC:
1685
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.23
DANN
Benign
0.25
PhyloP100
-0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2243288; hg19: chr5-132017944; COSMIC: COSV51503574; COSMIC: COSV51503574; API